When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ZGNX - Still near-100% upside in this pharma as rare-disease drug gets nod Needham says
Zogenix Inc.
Needham is unfazed by the boxed warning the FDA's requiring for Zogenix's (NASDAQ:ZGNX) Fintepla, approved yesterday evening by the FDA for the type of epilepsy called Dravet syndrome, calling the newly endorsed treatment "transformational," and reiterating its Buy rating on the company.
More news on: Zogenix, Inc., Healthcare stocks news, Notable Calls,